Regeneron Pharmaceuticals Inc (REGN)
Current ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 17,980,700 | 16,859,500 | 17,571,700 | 18,660,900 | 19,333,600 | 19,081,600 | 18,871,500 | 19,479,200 | 18,634,800 | 16,923,000 | 16,909,200 | 15,884,100 | 15,428,600 | 15,529,900 | 14,306,000 | 14,014,900 | 13,775,400 | 13,337,600 | 10,055,100 | 12,753,900 |
| Total current liabilities | US$ in thousands | 4,425,100 | 3,667,000 | 3,566,600 | 3,944,300 | 3,661,000 | 3,508,600 | 3,580,900 | 3,423,400 | 3,598,600 | 3,104,400 | 3,100,100 | 3,141,300 | 2,879,200 | 3,033,900 | 3,007,600 | 3,932,500 | 3,714,800 | 3,732,400 | 3,217,800 | 2,806,800 |
| Current ratio | 4.06 | 4.60 | 4.93 | 4.73 | 5.28 | 5.44 | 5.27 | 5.69 | 5.18 | 5.45 | 5.45 | 5.06 | 5.36 | 5.12 | 4.76 | 3.56 | 3.71 | 3.57 | 3.12 | 4.54 |
September 30, 2025 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $17,980,700K ÷ $4,425,100K
= 4.06
Peer comparison
Sep 30, 2025
Company name
Symbol
Current ratio
Regeneron Pharmaceuticals Inc
REGN
4.06
Arrowhead Pharmaceuticals Inc
ARWR
4.86
Biomarin Pharmaceutical Inc
BMRN
4.83
See also:
Regeneron Pharmaceuticals Inc Current Ratio (Quarterly Data)